news
El Financiero
2026-07-21
Ozempic Sues Eli Lilly Over 'Deceptive' Weight Loss Claims Using Outdated Studies
Novo Nordisk, maker of Ozempic, has sued competitor Eli Lilly for allegedly deceptive advertising regarding weight loss drugs. The lawsuit claims Eli Lilly used outdated studies to promote its products, Zepbound and Mounjaro.